ライフサイエンスコーパス: fibrocystic

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 (18:3n-6) was positively associated with all fibrocystic and cancerous conditions.

2 n normal and human breast cancer cell lines (fibrocystic and metastatic states) as well as normal and

3 and the n-7 saturation index against benign fibrocystic breast changes and the progression of prolif

4 ation of n-3 fatty acids with risk of benign fibrocystic breast changes.

5 Women who developed fibrocystic breast conditions classified as nonprolifera

6 eoporosis, breast cancer, endometriosis, and fibrocystic breast disease and has been hypothesized to

7 stic algorithm to distinguish normal tissue, fibrocystic change (FCC), fibroadenoma, and breast cance

8 ules and ducts, at higher levels in areas of fibrocystic change and papillomas, in all benign breast

9 t LOH occurs frequently in the components of fibrocystic change as well as in normal TDLUs and sugges

10 2 cases containing the various components of fibrocystic change in the absence of malignancy were stu

11 vivo samples of human breast tissue (normal, fibrocystic change, fibroadenoma, and infiltrating carci

12 Fibrocystic changes and benign fibroadenomas were identi

13 he breast and to evaluate the progression of fibrocystic changes in breast cancer.

14 Eight patients (4.4%) had benign results: fibrocystic changes in four, atypical ductal hyperplasia

15 These lesions display characteristics of fibrocystic changes observed in breasts of women, and in

16 RhoC was not expressed in any of the normal, fibrocystic changes, atypical hyperplasia, or ductal car

17 ystic conditions (PFCs) and nonproliferative fibrocystic conditions (NPFCs) in the breast and to eval

18 s in the development of benign proliferative fibrocystic conditions (PFCs) and nonproliferative fibro

19 l papilloma as the source of discharge, with fibrocystic disease and ductal ectasia providing the nex

20 l carcinoma, and the third had proliferative fibrocystic disease of the breast.

21 lls) of benign tumors from ten patients with fibrocystic disease of the breast.

22 ve polycystic kidney disease is a hereditary fibrocystic disease that involves the kidneys and the bi

23 There were no differences in breast fibrocystic disease, uterine fibroids, or endometrial li

24 benign conditions, such as fibroadenoma and fibrocystic disease.

25 pithelial cells obtained from a patient with fibrocystic disease.

26 e, as well as progressive retinal dystrophy, fibrocystic kidney disease, and liver fibrosis.

27 vealing 15 fibroadenomas, 12 carcinomas, six fibrocystic nodules, and 13 other lesions.

28 not with normal breast, benign papilloma, or fibrocystic tissue.

29 n of cancer as compared with both normal and fibrocystic tumor tissue was measured in all the samples

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。